From owner-chemistry@ccl.net Fri Dec 19 12:51:00 2014 From: "Paolo Nicolini nicolpao:+:fel.cvut.cz" To: CCL Subject: CCL: Conference on Nano and Mesoscale Friction, Istanbul, 22-26 June 2015 Message-Id: <-50836-141219123135-13810-U8S5dE6NcecHXrJ3Sk0TsA%server.ccl.net> X-Original-From: "Paolo Nicolini" Date: Fri, 19 Dec 2014 12:31:34 -0500 Sent to CCL by: "Paolo Nicolini" [nicolpao!^!fel.cvut.cz] Dear Colleagues, my apologies for cross posting. We are pleased to announce that the International Conference on Understanding and Controlling Nano And Mesoscale Friction will be held from 22nd to 26th of June 2015 in Istanbul, Turkey. This conference stems from a scientific community which has evolved over the years and is now coordinated through a COST Action. A great occasion to meet and discuss with leading scientists and industries active in the science and technology of of friction from the atomic scale up. The confirmed invited speakers are: Prof. Roland Bennewitz, Leibniz Institute for New Materials, Germany Prof. Robert W. Carpick, University of Pennsylvania, USA Prof. Elisabeth Charlaix, Universite Joseph Fourier, France Prof. Annalisa Fasolino, Radboud Universiteit Nijmegen, The Netherlands Dr. Enrico Gnecco, IMDEA Nanoscience, Spain Prof. Lev Kantorovich, King's College London, UK Prof. Jacob Klein, Weizmann Institute of Science, Israel Dr. Mark A. Lantz, IBM Research, Switzerland Prof. Liliane Leger, Universite Paris-Sud 11, France Prof. Nicola Manini, University of Milan, Italy Dr. C. Mathew Mate, ex HGST, a Western Digital company, USA Prof. Michael Moseler, Fraunhofer IWM, Germany Prof. Susan Perkin, University of Oxford, UK Abstracts submission will be open from 5th of January to 15th of February 2015. More information at http://www.costnanotribo.org We look forward to your participation. Best regards, Paolo Nicolini (on behalf of the Organizing Committee) From owner-chemistry@ccl.net Fri Dec 19 20:32:01 2014 From: "Jim Kress ccl_nospam[]kressworks.com" To: CCL Subject: CCL: descriptors for pridire anti-cancer activity? Message-Id: <-50837-141219193727-27821-xHXzIav4PDqeOc8cNCw1mA]*[server.ccl.net> X-Original-From: "Jim Kress" Content-Language: en-us Content-Transfer-Encoding: 7bit Content-Type: text/plain; charset="us-ascii" Date: Fri, 19 Dec 2014 19:37:14 -0500 MIME-Version: 1.0 Sent to CCL by: "Jim Kress" [ccl_nospam+/-kressworks.com] Simple question, very complex answers. Which cancer (there are over 300 types)? Which signaling or metabolic pathway? Which step in the multicomponent, mechanistic kinetics of the pathway? Which species in the cellular environment are involved? Is it a genomic, proteomic, lipidomic or other -omic process? Which Hallmark of Cancer is affected? Look here for a better understanding of what question you really want to ask: http://www.kressworks.org/page/The%20Confounding%20Complexity%20of%20Cancer (use FireFox or IE). Jim James Kress Ph.D., President The KressWorks Foundation C An IRS Approved 501 (c)(3) Charitable, Nonprofit Organization "Improving Lives One Atom At A Time" TM (248) 605-8770 Learn More and Donate At: http://www.kressworks.org -----Original Message----- > From: owner-chemistry+jimkress35==gmail.com**ccl.net [mailto:owner-chemistry+jimkress35==gmail.com**ccl.net] On Behalf Of ARDJANI taki takiaiman/ayahoo.fr Sent: Thursday, December 18, 2014 3:46 AM To: Kress, Jim Subject: CCL: descriptors for pridire anti-cancer activity? Sent to CCL by: "ARDJANI taki" [takiaiman(_)yahoo.fr] Dear CCL colleagues, I want to study theoretically the anti-cancer activity (MCF-7, MDA-MB-231), my question is: what are the best descriptors for pridire anti-cancer activity? ARDJANIhttp://www.ccl.net/cgi-bin/ccl/send_ccl_messagehttp://www.ccl.net/chemistry/sub_unsub.shtmlhttp://www.ccl.net/spammers.txt